Sale!
Tirz (GLP-1, GIP RA) 10mg
,

Tirz (GLP-1, GIP RA) 10mg

Original price was: $199.00.Current price is: $159.00.

& Free Shipping
SKU: EX417200-10MG Categories: ,
Guaranteed Safe Checkout

Tirz (GLP-1, GIP RA) 10mg: Advanced Dual-Receptor Support for Modern Weight Management and Metabolic Health

What Is Tirz (GLP-1, GIP RA) 10mg?

Tirz (GLP-1, GIP RA) 10mg is a dual incretin receptor agonist designed to support weight management and metabolic health by targeting two important hormone pathways: Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP). By activating both receptors, Tirz helps regulate appetite, improve satiety, and support healthy glucose metabolism.

Unlike traditional single-pathway therapies, the dual-action mechanism of Tirz offers a comprehensive approach to metabolic support. This innovative formulation has attracted significant attention among healthcare professionals and individuals seeking effective options for weight reduction and improved metabolic outcomes.

How Tirz 10mg Works

Dual GLP-1 and GIP Receptor Activation

Tirz 10mg works by mimicking the natural incretin hormones that play a crucial role in regulating blood sugar levels and appetite. The GLP-1 component helps slow gastric emptying, reduce hunger signals, and increase feelings of fullness after meals. Meanwhile, GIP receptor activation enhances the body’s metabolic response and may contribute to improved energy utilization.

Together, these mechanisms create a synergistic effect that supports healthier eating behaviors and improved metabolic function.

Appetite Control and Satiety Support

One of the primary benefits associated with Tirz is its ability to help individuals manage hunger more effectively. By influencing appetite-regulating pathways in the brain, Tirz may help reduce food cravings and support portion control, making it easier to maintain a calorie-conscious lifestyle.

Metabolic Health Benefits

In addition to supporting weight management goals, Tirz may help promote healthier metabolic parameters. Its dual-receptor activity is designed to assist with glucose regulation and overall metabolic efficiency when used under appropriate medical supervision.

Key Benefits of Tirz (GLP-1, GIP RA) 10mg

Enhanced Weight Management Support

Tirz 10mg is widely recognized for its potential role in comprehensive weight management programs. Combined with a balanced diet and regular physical activity, it may help individuals achieve and maintain their wellness objectives more effectively.

Improved Satiety and Reduced Hunger

Many users report increased feelings of fullness and a reduction in frequent hunger sensations. This effect can support healthier eating habits and contribute to long-term lifestyle improvements.

Comprehensive Metabolic Assistance

The dual-action nature of Tirz distinguishes it from many conventional options. By targeting both GLP-1 and GIP receptors, it offers a broader approach to metabolic support and appetite regulation.

Convenient Dosing Strength

The 10mg dosage is commonly utilized as part of a structured treatment plan prescribed by qualified healthcare professionals. Appropriate dosing should always be determined based on individual medical needs and treatment goals.

Why Tirz 10mg Stands Out

Innovative Dual-Incretin Technology

The combination of GLP-1 and GIP receptor agonism represents a significant advancement in metabolic science. This dual-target approach is designed to optimize the body’s natural hormonal responses involved in appetite and glucose control.

Supports Long-Term Wellness Goals

Sustainable weight management often requires more than dietary changes alone. Tirz 10mg may serve as a valuable component of a comprehensive wellness strategy that includes nutrition, exercise, and ongoing medical guidance.

Backed by Scientific Interest

Dual incretin therapies have become an important area of research within metabolic health and obesity management. Their growing popularity reflects increasing interest in treatments that address multiple physiological pathways simultaneously.

Important Considerations Before Use

Medical Supervision Is Essential

Tirz 10mg should only be used under the guidance of a qualified healthcare provider. A thorough medical evaluation is necessary to determine whether this therapy is appropriate for an individual’s health profile and treatment objectives.

Potential Side Effects

As with many incretin-based therapies, some individuals may experience gastrointestinal effects such as nausea, vomiting, diarrhea, or decreased appetite. Side effects can vary depending on personal health factors and treatment response.

Lifestyle Support Remains Important

For optimal results, Tirz 10mg should be integrated into a broader health and wellness plan. Healthy nutrition, regular physical activity, adequate hydration, and consistent medical follow-up are important components of successful long-term outcomes.

Conclusion

Tirz (GLP-1, GIP RA) 10mg represents a modern approach to weight management and metabolic health support through its innovative dual-receptor mechanism. By targeting both GLP-1 and GIP pathways, it may help promote appetite control, improved satiety, and healthier metabolic function. When used under professional medical supervision and combined with positive lifestyle habits, Tirz 10mg can play an important role in supporting long-term wellness goals and overall metabolic health.

CID

168009818
CAS

2023788-19-2
InChI

InChI=1S/C225H348N48O68/c1-23-126(10)183(264-198(311)146(64-50-52-88-226)246-202(315)157(109-180(297)298)252-199(312)152(103-124(6)7)261-223(337)225(21, 22)269-217(330)185(128(12)25-3)266-209(322)163(120-278)257-200(313)153(107-138-74-78-141(282)79-75-138)250-203(316)158(110-181(299)300)253-207(320)162(119-277)259-216(329)187(134(18)280)267-206(319)155(106-136-60-44-41-45-61-136)254-215(328)186(133(17)279)262-174(289)114-237-193(306)147(83-87-179(295)296)260-222(336)224(19, 20)268-192(305)143(227)104-137-72-76-140(281)77-73-137)214(327)242-131(15)190(303)244-148(80-84-168(228)283)196(309)245-145(65-51-53-89-231-175(290)121-340-100-99-339-97-91-233-176(291)122-341-101-98-338-96-90-232-170(285)86-82-150(221(334)335)243-171(286)70-46-38-36-34-32-30-28-26-27-29-31-33-35-37-39-47-71-178(293)294)195(308)240-130(14)191(304)248-154(105-135-58-42-40-43-59-135)205(318)263-182(125(8)9)212(325)247-149(81-85-169(229)284)197(310)251-156(108-139-111-234-144-63-49-48-62-142(139)144)201(314)249-151(102-123(4)5)204(317)265-184(127(11)24-2)213(326)241-129(13)189(302)236-112-172(287)235-115-177(292)270-92-54-66-164(270)210(323)258-161(118-276)208(321)256-160(117-275)194(307)238-113-173(288)239-132(16)218(331)272-94-56-68-166(272)220(333)273-95-57-69-167(273)219(332)271-93-55-67-165(271)211(324)255-159(116-274)188(230)301/h40-45, 48-49, 58-63, 72-79, 111, 123-134, 143, 145-167, 182-187, 234, 274-282H, 23-39, 46-47, 50-57, 64-71, 80-110, 112-122, 226-227H2, 1-22H3, (H2, 228, 283)(H2, 229, 284)(H2, 230, 301)(H, 231, 290)(H, 232, 285)(H, 233, 291)(H, 235, 287)(H, 236, 302)(H, 237, 306)(H, 238, 307)(H, 239, 288)(H, 240, 308)(H, 241, 326)(H, 242, 327)(H, 243, 286)(H, 244, 303)(H, 245, 309)(H, 246, 315)(H, 247, 325)(H, 248, 304)(H, 249, 314)(H, 250, 316)(H, 251, 310)(H, 252, 312)(H, 253, 320)(H, 254, 328)(H, 255, 324)(H, 256, 321)(H, 257, 313)(H, 258, 323)(H, 259, 329)(H, 260, 336)(H, 261, 337)(H, 262, 289)(H, 263, 318)(H, 264, 311)(H, 265, 317)(H, 266, 322)(H, 267, 319)(H, 268, 305)(H, 269, 330)(H, 293, 294)(H, 295, 296)(H, 297, 298)(H, 299, 300)(H, 334, 335)
InChIKey

BTSOGEDATSQOAF-UHFFFAOYSA-N
Canonical SMILES

CCC(C)C(C(=O)NC(C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)C(=O)NC(C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NCC(=O)NCC(=O)N4CCCC4C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N5CCCC5C(=O)N6CCCC6C(=O)N7CCCC7C(=O)NC(CO)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C)(C)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(CC8=CC=C(C=C8)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC9=CC=CC=C9)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC1=CC=C(C=C1)O)N
IUPAC Name

20-[[4-[2-[2-[2-[2-[2-[2-[[5-[[5-amino-2-[2-[[2-[[6-amino-2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-2-methylpropanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-2-methylpropanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]propanoylamino]-5-oxopentanoyl]amino]-6-[[1-[[1-[[1-[[5-amino-1-[[1-[[1-[[1-[[1-[[2-[[2-[2-[[1-[[1-[[2-[[1-[2-[2-[2-[(1-amino-3-hydroxy-1-oxopropan-2-yl)carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1, 5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-6-oxohexyl]amino]-2-oxoethoxy]ethoxy]ethylamino]-2-oxoethoxy]ethoxy]ethylamino]-1-carboxy-4-oxobutyl]amino]-20-oxoicosanoic acid
Molecular Formula

C225H348N48O68
Molecular Weight

4813
Monoisotopic Mass

4810.5248574
Polar Area

1790
Complexity

11700
XLogP

-6.8
Heavy Atom Count

341
Hydrogen Bond Donor Count

58
Hydrogen Bond Acceptor Count

70
Rotatable Bond Count

163
Physical Appearance

Fine White Lyophilized Powder
Stability

Lyophilized protein is to be stored at -20°C. It is recommended to aliquot the reconstituted (dissolved) protein into several discrete vials in order to avoid repeated freezing and thawing. Reconstituted protein can be stored at 4°C

Related products